These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38818946)
61. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Rumondor AC; Marsac PJ; Stanford LA; Taylor LS Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917 [TBL] [Abstract][Full Text] [Related]
62. Thermodynamic Solubility Profile of Carbamazepine-Cinnamic Acid Cocrystal at Different pH. Keramatnia F; Shayanfar A; Jouyban A J Pharm Sci; 2015 Aug; 104(8):2559-65. PubMed ID: 26096952 [TBL] [Abstract][Full Text] [Related]
63. Amorphous is not always better-A dissolution study on solid state forms of carbamazepine. Jensen LG; Skautrup FB; Müllertz A; Abrahamsson B; Rades T; Priemel PA Int J Pharm; 2017 Apr; 522(1-2):74-79. PubMed ID: 28263832 [TBL] [Abstract][Full Text] [Related]
64. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients. Widanapathirana L; Tale S; Reineke TM Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484 [TBL] [Abstract][Full Text] [Related]
65. Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions. Chen C; Xie X; Li Y; Zhou C; Song Y; Yan Z; Yang X Drug Dev Ind Pharm; 2014 Apr; 40(4):441-51. PubMed ID: 23614831 [TBL] [Abstract][Full Text] [Related]
66. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Ullah M; Hussain I; Sun CC Drug Dev Ind Pharm; 2016; 42(6):969-76. PubMed ID: 26460090 [TBL] [Abstract][Full Text] [Related]
67. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions. Jackson MJ; Kestur US; Hussain MA; Taylor LS Pharm Res; 2016 May; 33(5):1276-88. PubMed ID: 26892947 [TBL] [Abstract][Full Text] [Related]
68. Crystal growth formation in melt extrudates. Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578 [TBL] [Abstract][Full Text] [Related]
69. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Matsumoto T; Zografi G Pharm Res; 1999 Nov; 16(11):1722-8. PubMed ID: 10571278 [TBL] [Abstract][Full Text] [Related]
70. Investigation of the formation of drug-drug cocrystals and coamorphous systems of the antidiabetic drug gliclazide. Aljohani M; MacFhionnghaile P; McArdle P; Erxleben A Int J Pharm; 2019 Apr; 561():35-42. PubMed ID: 30802549 [TBL] [Abstract][Full Text] [Related]
71. The influence of polymeric excipients on desupersaturation profiles of active pharmaceutical ingredients. 1: Polyethylene glycol. Schneider R; Taspinar L; Ji Y; Sadowski G Int J Pharm; 2020 May; 582():119317. PubMed ID: 32320721 [TBL] [Abstract][Full Text] [Related]
72. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions. Knopp MM; Nguyen JH; Becker C; Francke NM; Jørgensen EB; Holm P; Holm R; Mu H; Rades T; Langguth P Eur J Pharm Biopharm; 2016 Apr; 101():145-51. PubMed ID: 26899127 [TBL] [Abstract][Full Text] [Related]
73. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin. Shi X; Song S; Ding Z; Fan B; Huang W; Xu T J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482 [TBL] [Abstract][Full Text] [Related]
74. Characterization and stability of solid dispersions based on PEG/polymer blends. Bley H; Fussnegger B; Bodmeier R Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875 [TBL] [Abstract][Full Text] [Related]
75. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Caron V; Tajber L; Corrigan OI; Healy AM Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367 [TBL] [Abstract][Full Text] [Related]
76. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME. Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416 [TBL] [Abstract][Full Text] [Related]
77. The Binary System of Ibuprofen-Nicotinamide Under Nanoscale Confinement: From Cocrystal to Coamorphous State. Bi Y; Xiao D; Ren S; Bi S; Wang J; Li F J Pharm Sci; 2017 Oct; 106(10):3150-3155. PubMed ID: 28625724 [TBL] [Abstract][Full Text] [Related]
78. Selective Acceleration of Crystal Growth of Indomethacin Polymorphs by Low-Concentration Poly(ethylene oxide). Shi Q; Zhang J; Zhang C; Jiang J; Tao J; Zhou D; Cai T Mol Pharm; 2017 Dec; 14(12):4694-4704. PubMed ID: 29125764 [TBL] [Abstract][Full Text] [Related]
80. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies. Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]